|
|
This is only a preview of the paper
Click here to register and get the full text.
Existing members click here to login
|
|
|
The use of Recombinant DNA Technology can only Benefit Humans.
The term recombinant DNA technology simply refers to the transfer of a gene from one organism to another organism: literally the recombination of DNA from different sources. The objective of recombinant DNA technology include firstly identifying genes, isolating genes, modifying genes, and re-expressing genes in other hosts or organisms. ...
One main use of recombinant DNA technology is to produce recombinant proteins. ... Proteins are made combining the DNA from one organism with the DNA of another organism.
This method can be used to make recombinant insulin this is an example of a very successful method of genetic engineering. ... The recombinant protein is either secreted or extracted from these cells. Transgenic animals on the other hand can be fermentation vessel themselves and secrete recombinant proteins into their milk. ...
Another important use for recombinant proteins is as agents for the treatment of specific diseases, but this is not their only use. ...
The production of recombinant proteins has provided scientist with sufficient information for them to study their function and to allow proteins with un-known functions to be characterised. This becoming more important as more complete DNA sequences for the human genome become available. ...
From the examples previously stated it would seem that the reproduction of recombinant proteins is relatively easy and straightforward. ...
Another form of Recombinant DNA is gene therapy. ... Like other new forms of recombinant DNA technology, gene therapy raises ethical and social issues. ...
A third main use of Recombinant DNA technology is genetically modified crops. ...
There seem to be many advantages of recombinant DNA technology but these are accompanied with the disadvantages.
Approximate Word count = 1332
Approximate Pages = 5.3
(250 words per page double spaced)
|
|
|
|
|
|